Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MONTRÉAL--(BUSINESS WIRE)--gIcare Pharma Inc today announced the initiation of a phase 2a study of GIC-1001, a novel orally-administered opioid agonist drug candidate to provide sedation-free, colonic analgesia in patients undergoing colonoscopy.
Help employers find you! Check out all the jobs and post your resume.
MONTRÉAL--(BUSINESS WIRE)--gIcare Pharma Inc today announced the initiation of a phase 2a study of GIC-1001, a novel orally-administered opioid agonist drug candidate to provide sedation-free, colonic analgesia in patients undergoing colonoscopy.
Help employers find you! Check out all the jobs and post your resume.
